Mayo Clinic Cancer Center | Strategic Alliance Partners

Latest from Mayo Clinic Cancer Center

NCCN Guidelines Include an Abundance of Options Across Multiple Myeloma Paradigm

March 30, 2021

The National Comprehensive Cancer Network guidelines for the management of frontline and relapsed/refractory multiple myeloma were updated to incorporate novel agents and combination strategies, providing a wide range of category 1 recommended therapies for patients.